NCT00088400View on ClinicalTrials.gov

Comparison of TransMID vs Standard Treatment of Cancerous Brain Tumors

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

November 30, 2005

Conditions
Glioblastoma
Interventions
DRUG

TransMID

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00088400 - Comparison of TransMID vs Standard Treatment of Cancerous Brain Tumors | Biotech Hunter | Biotech Hunter